Raloxifene Hydrochloride Hydrate is a pharmaceutical-grade active ingredient used in the manufacture of medications for postmenopausal women. It is a Selective Estrogen Receptor Modulator (SERM) that mimics estrogen’s beneficial effects on bone while blocking estrogen’s effects in breast tissue. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include raloxifene hydrochloride monohydrate and Raloxifene hydrochloride hydrate [JAN]. Its PubChem CID is 24772103.
Raloxifene hydrochloride hydrate
| CAS No | 1020061-04-4 |
|---|---|
| Molecular Formula | C28H30ClNO5S |
| Molecular Weight | 528.1 g/mol |
| Synonyms | [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrate;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Raloxifene Hydrochloride Hydrate is a pharmaceutical-grade active ingredient used in the manufacture of medications for postmenopausal women. It is a Selective Estrogen Receptor Modulator (SERM) that mimics estrogen’s beneficial effects on bone while blocking estrogen’s effects in breast tissue.
The listed CAS number is 1020061-04-4.
The listed molecular formula is C28H30ClNO5S.
The listed molecular weight is 528.1 g/mol.
[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrate;hydrochloride.
The source lists raloxifene hydrochloride monohydrate and Raloxifene hydrochloride hydrate [JAN].